CBF and CMRO2 during continuous etomidate infusion supplemented with N2O and fentanyl in patients with supratentorial cerebral tumour. A dose-response study

Acta Anaesthesiol Scand. 1985 Jul;29(5):490-4. doi: 10.1111/j.1399-6576.1985.tb02240.x.

Abstract

In 14 patients with supratentorial cerebral tumours with midline shift below 10 mm, CBF and CMRO2 were measured (Kety & Schmidt) during craniotomy. The anaesthesia was continuous etomidate infusion supplemented with nitrous oxide and fentanyl. The patients were divided into two groups. In Group 1 etomidate infusion of 30 micrograms kg-1 min-1 was used throughout the anaesthesia, and CBF and CMRO2 were measured twice. In this group CMRO2 (means +/- s.d.) averaged 2.31 +/- 0.43 ml O2 100 g-1 min-1 70 min after induction and 2.21 +/- 0.38 ml O2 100 g-1 min-1 130 min after induction. In Group 2 the etomidate infusion was increased from 30 to 60 micrograms kg-1 min-1 after the first study and a significant fall in CMRO2 from 2.52 +/- 0.56 to 1.76 +/- 0.40 ml O2 100 g-1 min-1 was found. Simultaneously, a significant fall in CBF was observed. The CO2 reactivity was preserved during anaesthesia.

MeSH terms

  • Adult
  • Aged
  • Anesthetics / pharmacology*
  • Brain / metabolism*
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / secondary
  • Brain Neoplasms / surgery
  • Carbon Dioxide / blood
  • Cerebrovascular Circulation* / drug effects
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Etomidate / pharmacology*
  • Female
  • Fentanyl / pharmacology*
  • Humans
  • Imidazoles / pharmacology*
  • Male
  • Meningioma / metabolism
  • Meningioma / surgery
  • Middle Aged
  • Nitrous Oxide / pharmacology*
  • Oligodendroglioma / metabolism
  • Oligodendroglioma / surgery
  • Oxygen Consumption / drug effects

Substances

  • Anesthetics
  • Imidazoles
  • Carbon Dioxide
  • Nitrous Oxide
  • Fentanyl
  • Etomidate